(MedPage Today) — While there’s little disagreement that speeding drug approvals would be a good thing, there are more questions than answers about the FDA’s new national priority voucher program, experts told MedPage Today.
Earlier this month…
Source link : https://www.medpagetoday.com/washington-watch/fdageneral/116275
Author :
Publish date : 2025-06-26 21:34:00
Copyright for syndicated content belongs to the linked Source.
